UCSF scientist rolls out a new blueprint for programming T cells, the 2.0 way
While analysts debate about whether or not the FDA will be willing to hand out the first CAR-T approval to Kite, the scientists in this burgeoning field have been laboring in the lab on next-gen T cell therapy models that have a lot more built-in safety and efficacy features. One of the top cell therapy engineers is Wendell Lim at UC San Francisco, the scientific founder of Cell Design Labs. And he’s just come out with a new paper on his work featuring some of the cool new technologies that he’s been using on T cells 2.0.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.